Market Research Report: Monod Bio
Company Overview
Name, Mission of the Company
- Name: Monod Bio
- Mission of the Company: To revolutionize life sciences tools and clinical diagnostics using AI-powered protein design.
Founding Information
- Founding Date: 2022
- Founders:
- Daniel Silva Manzano, PhD
- David Shoultz, PhD, MBA
- Alfredo Quijano Rubio, PhD
- David Baker, PhD (Scientific Advisor, Founding Director of IPD)
Key People in the Company
- Daniel Silva Manzano, PhD: Co-Founder, CEO, and Board Member
- David Shoultz, PhD, MBA: Co-Founder, COO, and Board Member
- Alfredo Quijano Rubio, PhD: Co-Founder, CSO, and Board Observer
- Greg Tibitts, CPA, MBA: Fractional CFO
- David Baker, PhD: Founding Director, IPD, Scientific Advisor
- Timothy Still, MBA: Strategic Advisor
- Dave Johnson: Chair, Board of Directors
- Karan Takhar: Board Member
- Melina Cimler, PhD: Board Member
Headquarters
- Location: 700 Dexter Avenue N, Suite 700, Seattle, WA 98109
Number of Employees
- No information is available
Revenue
- No information is available
What is the Company Known For
- AI-powered de novo protein design for the development of research-use-only (RUO) tools and in vitro diagnostics (IVD).
Products
Overview
Monod Bio offers a range of products focused on de novo protein design, specifically in the areas of luminescence assays and protein-protein interaction systems.
Product List
LuxSit™ Pro Luciferase Assay System
- Description:
- Generates high-intensity glow-type luminescence multiple times brighter than commonly used luciferase systems.
- Key Features:
- Small, hyper-stable de novo luciferase
- Bright and linear dynamic range
- Highly specific proprietary synthetic substrate
- Peak light emission at 500nm
LuxSit™ s-Pro Protein:Protein Interaction System
- Description:
- A versatile two-component split reporter system.
- Key Features:
- Split LuxSit™ Pro Luciferase System
- Enables Protein:Protein interaction (PPI) research
- Low assay background
- High signal-to-noise upon split enzyme reconstitution
Recent Developments
Recent Developments in the Company
- Monod Bio, as a spin-out from the Baker Lab, has continued to push the innovation boundaries in protein design using AI.
New Products Launched
- LuxSit™ Pro Luciferase Assay System
- LuxSit™ s-Pro Protein:Protein Interaction System
New Features Added to Existing Products
- No information is available
New Partnerships
- No information is available
Press Coverage
News & Press Releases
- Nature: De novo design of luciferases using deep learning.
- The Wall Street Journal: Biotech Startup Monod Bio Collects $25 Million Seed Financing.
- Endpoints News: David Baker lab spinout scores seed funding to build a biosensor from engineered protein.
- Crunchbase: Monod Bio Raises $25M To Quickly Diagnose Diseases.
- Geekwire: Institute for Protein Design spinout Monod Bio raises $25M for molecular biosensors.
Contact Information
- Address:
- 700 Dexter Avenue N, Suite 700, Seattle, WA 98109, US
- Website:
- [Monod Bio Official Website](https://www.monodbio.com)
© 2024 Monod Bio. All Rights Reserved. Privacy Statement Terms of Use Opt-out preferences Site by BKW.
